OBJECTIVE: To investigate the effects of weight loss on sex hormone-binding globulin (SHBG) in massively obese males and whether normal SHBG concentrations could be obtained regardless or not of the achievement of normal body weight values. DESIGN AND SUBJECTS: Sera were collected for SHBG determination from 63 massively obese men, partly before they underwent biliopancreatic diversion (pre-op group 11) and partly during the post-surgical follow up (post-op group 52), and twenty normal weight healthy control men. MEASUREMENTS: Serum SHBG was measured using a noncompetitive liquid-phase immunoradiometric assay. RESULTS: Baseline general characteristics were similar in both obese groups. Obese patients in the post-op group had lost 46.4 AE 2.9 kg since they had undergone operation, namely during a mean period of 14.9 AE 13.8 (range 1±58) months follow up. Obese groups had signi®cantly lower SHBG than normal weight controls (66.2 AE 18.6 nmol/l). However, preop obese (19.9 AE 5.5 nmol/l) had signi®cantly lower values than post-op obese subjects (45.5 AE 24.8 nmol/l; P`0.001). There were a highly signi®cant correlation between SHBG and individual BMI values (r 7 0.629; P`0.001). Moreover, the post-op obese with BMI values lower or equal to 28 had signi®cantly higher SHBG concentrations than those with BMI greater than 28 (62.8 AE 22.2 nmol/l vs 32.1 AE 19.6 nmol/l; P`0.001), but not signi®cantly different with respect to normal weight controls. CONCLUSIONS: Massively obese men weight loss can completely reverse SHBG abnormalities, which can be restored to the normal range when near-normal body weight is achieved. Since reduced SHBG concentrations can be an independent risk factor for the development of diabetes and cardiovascular disease, this represents an additional bene®t of weight loss program in massively obese individuals.
Introduction
Sex hormone-binding globulin (SHBG) blood concentrations are inversely correlated to body weight and body mass index in both sexes. 1 Therefore, obese individuals have lower mean SHBG levels than normal healthy subjects. Weight loss is usually followed by an increase of SHBG, 2±5 although contradictory results have been reported. 6, 7 Recently, Strain and coworkers 4 suggested that in obese men losing weight, the increase of SHBG per unit decrease of BMI may be higher than that predicted on the basis of the pretreatment negative slope between SHBG and BMI. On the other hand it is not still clear whether weight loss may per se normalize SHBG concentrations nor how much weight an obese patient must lose to achieve SHBG concentrations similar to those of normal weight healthy individuals. Normalization of SHBG may be of importance, since reduced SHBG concentrations alter androgen availability at the level of target tissues. 8 Moreover, several studies have demonstrated that lowered SHBG levels represent an independent risk factor for diabetes 9 and also for cardiovascular disease. 10 We therefore carried out this study to investigate: (1) effects of weight loss on SHBG blood concentrations and, (2) whether normal SHBG concentrations can be obtained regardless or not of the achievement of normal body weight values.
Materials and methods

Samples and patients
We analyzed 63 serum samples collected from massively obese male patients examined at the Institute of Surgical Pathology, of the S. Martino Hospital, Genoa, Italy. Some of the patients were on the waiting list for biliopancreatic diversion (Group pre-op, n 11), whereas others (Group post-op, n 52) had been previously treated surgically and had been enrolled in a long-term post-surgical follow-up. Theory and methodology of the biliopancreatic diversion have already been extensively reported. 11 The following patient data were recorded: age, height, body weight (at the time when blood samples were drawn), maximum body weight during their life, preoperation body weight, total weight loss (pre-surgical body weight minus post-surgical weight loss), and duration (in months) of the post-surgical follow-up. Moreover, a complete clinical history was available, including dietary habits and medication use. None of the patients were dieting, regardless of whether they were investigated pre-operatively or during post-surgical follow up.
None had clinical signs of poor nutritional status, although several of them presented some biochemical alterations (see below) which are commonly present after this surgical procedure, as previously reported. 12 In the post-op group, 25 (64%) were taking vitamin D supplementation and 22 (38%) took ranitidine or omeprazole. Other medications included calcium (6 pts), aspirin (1 pt), furosemide (1 pt), spironolactone (1 pt) and calcium channel blockers (2 pts). General data of the obese patients are summarized in Table 1 . Blood samples were drawn from an antecubital arm vein in the morning, after overnight fasting, for routine biochemical evaluation. Aliquots of sera samples were then stored at À20 C until assay. More relevant biochemical parameters of the obese subjects included in each group are also reported in Table 1 .
For comparison, we used data obtained from a control group consisting of 20 normal weight nonobese males, whose general characteristics have previously been reported elsewhere. 13 
SHBG assay and biochemistry
Blood samples for SHBG were maintained at À20 C until assay, which was performed using a noncompetitive liquid-phase immunoradiometric assay with reagents obtained from Orion Diagnostica, Espoo, Finland. Intra-and inter-assay coef®cients of variation in our laboratory are 8.0 and 14.0%, respectively, and lower sensitivity limit is 0.5 nmol/l. Principal biochemical parameters, which are listed in Table 1 , were determined by using routine laboratory techniques by the 747 Automatic Analyzer, Hiachi Boering, Mannheim, Germany, and the Coulter STKS Automatic Analzyer, Miami, Florida, USA.
Statistics
Comparison between the groups group data were performed by using the Mann Whitney U test and relationship between different variables were analyzed by the Spearman's correlation coef®cient. Data are presented as mean AE standard deviation (s.d.). P values at the 0.05 were considered as signi®cant.
Results
Subjects
Age values were similar in obese and control subjects. Anthropometric data of massively obese patients included in the pre-op and post-op groups are reported in Table 1 . There was no signi®cant difference between the groups in age, pretreatment body weight and BMI and maximum body weight achieved during life. Patients in the post-op group had lost 46.4 AE 23.9 kg since they had undergone operation (range: 13±103 kg), and their BMI had been decreased by 32.3 AE 12.8%. The duration of the follow-up in this group was 14.9 AE 13.8 months (range: 1±58 months), with a rate of weight loss of 6.7 AE 5.6 kg per month (range 0.45±21.00 kg). Body weight in controls was 70.5 AE 8.0 and BMI 23.0 AE 2.0. Both pre-op (P`0.0001) and post-op obese subjects (P`0.001) and BMI values higher than control subjects.
SHBG concentrations
SHBG serum levels in the group of obese examined before surgery were signi®cantly lower (19.9 AE 5.6 nmol/l) than those observed in the postop group (45.5 AE 24.8 nmol/l; P`0.001) (Figure 1 ). Figure 1 Sex hormone-binding globulin concentrations in massively obese patients examined before (j) and after (u) biliopancreatic diversion and in normal weight controls (u).
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In both groups, however, SHBG concentrations were signi®cantly lower than those of the normal weight controls (66.2 AE 18.6 nmol/l; P`0.001 and 0.05, respectively). There was a signi®cant negative correlation between BMI and SHBG (r À0.629; P`0.0001). Moreover, in the post-op group, SHBG was positively correlated with total weight loss after surgery (r 0.618; P`0.001) (Figure 2, top) . We divided post-op patients into two groups, according to their BMI values. Those with a BMI lower or equal to 28 had signi®cantly higher SHBG concentrations than those with BMI greater than 28 (62.8 AE 22.2 nmol/l vs 32.1 AE 19.6 nmol/l; P`0.001) (Figure 2, bottom) . Contrary to the latter, SHBG values in the former group were not signi®cantly different with respect to the normal weight controls (66.2 AE 18.6 nmol/l).
Biochemistry
Principal biochemical parameters are reported in Table 1 . Compared to pre-op obese, patients of the post-op group had signi®cantly lower mean values of red blood cell count and haemoglobin, glucose, total cholesterol, total protein, albumin and calcium. None of the obese patients were below the lower normal range values in the pre-op group and one had fasting hyperglycemia consistent with type 2 diabetes. On the contrary, glucose values were in the normal range in all the post-op obese. However, several of them had lower than normal blood values for haemoglobin (36%), total cholesterol (11%), calcium (15%), total proteins (15%), and albumin (2%). Moreover, haemoglobin, triglycerides and total protein values were signi®cantly lower (P`0.05) in the post-op patients with BMI lower than 28 when compared with those a Normal range is referred to reference values in our laboratory. *P`0.05; ** P`0.01. Pre-op and post-op means pre-and post-operation.
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Discussion
The results of the present study demonstrate that in massively obese male patients weight loss is associated with a progressive increase of SHBG blood concentrations, which can be restored into the normal range (namely that observed in the nonobese healthy subjects) when near-normal body mass index is achieved. At least in obese males, SHBG concentrations appear to be closely related to the excess body weight 13±15 rather than to the pattern of body fat distribution, although some authors 16 described an inverse and independent relationship between SHBG levels and visceral fat area. Nevertheless, there are no studies demonstrating that weight loss can completely restore SHBG concentrations to normality in postobese males. In fact, although several studies reported the effects of weight loss on SHBG variation, a partial increase of SHBG was reported only by some of them, 3±5 whereas others failed to observe any signi®-cant variation, in spite of sustained weight loss. 6 Similar ®ndings were observed in obese women without clinical signs or symptoms of hyperandrogenism, in whom SHBG concentrations have been found unchanged 7 or slightly increased, 5 regardless of the degree of weight loss. Our data indicate, on the contrary, that changes of SHBG during weight loss largely depend on the amount of weight lost, at least in male subjects, and that normal SHBG concentrations can be achieved only in post-obese patient with near-normal body mass index. Therefore, these data con®rm and extend what previously suggested by Strain et al 4 who found an inverse essentially linear relationship between BMI and SHBG in male subjects losing weight. It obviously follows that one would not reach normal SHBG concentrations with weight loss till near-normal weight is achieved, thus explaining contradictory results reported in several previously published studies.
3±7
Although several dietary factors, including lipids and carbohydrates, may regulate SHBG concentrations, 8 it is unlikely that changes in SHBG may be primarily related to diet composition or to subtle alterations of the nutritional status in post-op obese subjects. In fact, in the post-ob obese patients the directions of SHBG variation during weight loss was opposite to that observed for several biochemical parameters, therefore excluding that post-surgical malnutrition may be directly responsible for SHBG modi®cations.
Mechanisms by which SHBG can be restored to normality in post-obese male patients are only speculative. However, among other several factors, 8, 17 there is evidence for a key regulatory role of insulin. 18 Several epidemiological studies have in fact demonstrated that insulin and SHBG concentrations are inversely correlated, regardless of age, body weight and fat distribution. 14, 19 Moreover, in vitro and in vivo studies have shown that insulin can inhibit SHBG synthesis. 20, 21 We could not measure insulin concentrations, which makes any speculation on the role of insulin impossible. On the other hand, it has been largely demonstrated that in obese hyperinsulinemic patients submitted to therapeutic procedures, changes in insulin concentrations parallel that of weight loss. This has been previously demonstrated, for example, even in massively obese patients treated with the biliopancreatic diversion, during a long-term postsurgical follow up. 22 Therefore, it can be suggested that normalization of insulin levels represents the prerequisite to achieve normal SHBG levels in the post-obese subjects. This may be of importance since both insulin-resistance with associated hyperinsulinemia and reduced SHBG concentrations represent Figure 2 Correlation between SHBG concentrations and weight loss (top) and mean values in massively obese patients after biliopancreatic bypass, who achieved body mass index (BMI) values equal or lower (j) and higher (u) than 28, and in normal weight controls (u) (bottom).
Obesity, weight loss and SHBG R Pasquali et al independent risk factors for diabetes and cardiovascular diseases. 9, 10 In this view, achieving normal SHBG concentrations together with normal insulin concentrations and peripheral sensitivity, could represent a precise goal in the treatment of obesity, particularly in young and middle-age individuals.
